What does CUSIP 45168K306 represent in this 13F holders report?

CUSIP 45168K306 is the security identifier for IDRA - IDERA PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held IDRA - IDERA PHARMACEUTICALS INC - COM NEW in Q2 2017?

75 institutional investors reported IDRA - IDERA PHARMACEUTICALS INC - COM NEW for Q2 2017. Use the holders table for investor-level position and value details.

IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

CUSIP: 45168K306

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / COM NEW
Total 13F shares: 46,289,190
Share change: -225,281
Total reported value: $79,615,014
Put/Call ratio: 313%
Price per share: $1.72
Number of holders: 75
Value change: -$708,191
Number of buys: 33
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 45168K306?
CUSIP 45168K306 identifies IDRA - IDERA PHARMACEUTICALS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 45168K306:

Q4 2019 Q3 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q2 2017

As of 30 Jun 2017, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,289,190 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, Broadfin Capital, LLC, FMR LLC, NATIXIS, JPMORGAN CHASE & CO, STATE STREET CORP, NORTHERN TRUST CORP, and Point72 Asset Management, L.P.. This page lists 75 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.